AKT1 and type 2 diabetes mellitus: A postmortem study found that the expression of PI3K/AKT was reduced in the frontal cortex in both T2D and AD patients (Liu et al. 2011) suggesting that T2D inhibits brain expression of PI3K/AKT and increase risk of AD.